{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:52:38Z","timestamp":1753890758344,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Conditional survival (CS) offers a more precise assessment of prognosis by continuously updating to reflect the current state. This study aimed to analyze the CS outcome of redefined anaplastic thyroid carcinoma (rATC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cohort comprising 1424 patients diagnosed with rATC between 2000 and 2018 was extracted from the Surveillance, Epidemiology, and End Results database and subsequently divided into training and validation sets at a ratio of 3:1. We analyzed the CS prognosis of these patients. A Lasso Cox regression model was employed to determine independent risk factors for long-term survival and to develop a predictive nomogram integrating CS analysis, aiming to provide CS estimates and stratify the risk among rATC patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The likelihood of achieving 5-year CS escalated from 8% after diagnosis to 44%, 68%, 82%, and 95% after 1, 2, 3, and 4 years of survival, respectively. As patients endured longer, their probability of further years of survival augmented. The Lasso Cox regression analysis identified age, tumor stage, surgery, radiotherapy and chemotherapy as the most influential prognostic factors associated with outcomes. Ultimately, we successfully established a novel CS-nomogram, aiming to provide dynamic survival updates for these patients. Our predictive model can quantify patients\u2019 risk and stratify it accordingly. Furthermore, after evaluation, the performance of our predictive model was found to be satisfactory.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Utilizing extensive SEER datasets, we devised and validated a CS-nomogram, enabling the prediction of the conditional probability of survival for rATC patients. This facilitates the incorporation of survivorship duration into prognostic assessments.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1525869","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:10:41Z","timestamp":1749528641000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of conditional survival outcomes in patients with redefined anaplastic thyroid carcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Yinuo","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhen","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0662","article-title":"Thyroid cancer incidence and mortality trends in the United States: 2000-2018","volume":"32","author":"Uchechukwu","year":"2022","journal-title":"Thyroid"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12032-020-1345-2","article-title":"Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer","volume":"37","author":"Daniela","year":"2020","journal-title":"Med Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.3362","article-title":"Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019","volume":"6","author":"Anastasios","year":"2020","journal-title":"JAMA Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.10.010","article-title":"Diagnosis and management of anaplastic thyroid cancer","volume":"48","author":"Ashish","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0944","article-title":"American thyroid association guidelines for management of patients with anaplastic thyroid cancer","volume":"31","author":"Keith","year":"2021","journal-title":"Thyroid"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0322","article-title":"Combination of lenvatinib and pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma","volume":"31","author":"Christine","year":"2021","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030552","article-title":"Evaluation of the 8th edition tnm classification for anaplastic thyroid carcinoma","volume":"12","author":"Naoyoshi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Zubair","year":"2022","journal-title":"Endocr Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/15330338241254059","article-title":"A competing risk nomogram for prediction of prognosis in patients with primary squamous cell thyroid carcinoma","volume":"23","author":"Ye","year":"2024","journal-title":"Technol Cancer Res Treat"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.06.009","article-title":"Risk-dependent conditional survival analysis and annual hazard rate of inflammatory breast cancer","volume":"49","author":"Xiangdi","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2023.11.018","article-title":"Prognosis and conditional survival among women with newly diagnosed ovarian cancer","volume":"180","author":"Elizabeth","year":"2024","journal-title":"Gynecol Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000472","article-title":"Conditional survival of Malignant thymoma using national population-based surveillance, epidemiology, and end results (SEER) registry (1973-2011)","volume":"10","author":"Ellen","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082184","article-title":"Conditional probability of survival and prognostic factors in long-term survivors of high-grade serous ovarian cancer","volume":"12","author":"Michel","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.311","article-title":"Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological Malignancies","volume":"27","author":"VanderWalde","year":"2013","journal-title":"Leukemia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz001","article-title":"Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer","volume":"30","author":"Dong","year":"2019","journal-title":"Ann Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13045-022-01225-3","article-title":"Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients","volume":"15","author":"Renjie","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4117","article-title":"Development and validation of a novel nomogram for individualized prediction of survival in cancer of unknown primary","volume":"27","author":"Kanwal","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-024-02495-2","article-title":"Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database","volume":"29","author":"Chuyue","year":"2024","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05302-z","article-title":"Development and validation of a nomogram for predicting the early death of anaplastic thyroid cancer: a SEER population-based study","volume":"149","author":"Hanxiao","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03085-w","article-title":"Risk stratification in patients with anaplastic thyroid carcinoma: role of age","volume":"77","author":"Mingjun","year":"2022","journal-title":"Endocrine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0574","article-title":"Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany","volume":"175","author":"Julia","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03662-7","article-title":"Surgery combined with adjuvant radiation and chemotherapy prolonged overall survival in stage IVC anaplastic thyroid cancer: a SEER-based analysis","volume":"85","author":"Ying","year":"2024","journal-title":"Endocrine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04223-7","article-title":"Role of surgery to the primary tumor in metastatic anaplastic thyroid carcinoma: pooled analysis and SEER-based study","volume":"149","author":"Dmytro","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.738213","article-title":"Burden of thyroid cancer from 1990 to 2019 and projections of incidence and mortality until 2039 in China: findings from global burden of disease study","volume":"12","author":"Fang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-019-05098-5","article-title":"Prognostic characteristics of primary squamous cell carcinoma of the thyroid: a national cancer database analysis","volume":"44","author":"Jessica","year":"2020","journal-title":"World J Surg"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1525869\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:10:41Z","timestamp":1749528641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1525869\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":25,"alternative-id":["10.3389\/fendo.2025.1525869"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1525869","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"article-number":"1525869"}}